Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 27:10:2045125320950124.
doi: 10.1177/2045125320950124. eCollection 2020.

A survey of UK general practitioners about depression, antidepressants and withdrawal: implementing the 2019 Public Health England report

Affiliations

A survey of UK general practitioners about depression, antidepressants and withdrawal: implementing the 2019 Public Health England report

John Read et al. Ther Adv Psychopharmacol. .

Abstract

Background: In 2019, a literature review indicated that more than half of people who try to come off antidepressants experience withdrawal effects. Both the National Institute of Health and Care Excellence and the Royal College of Psychiatrists updated their positions in line with that review, and Public Health England published a 152-page report called Dependence and withdrawal associated with some prescribed medicines: an evidence review. The report made several recommendations relevant to general practice.

Method: In order to facilitate implementation of these recommendations, an online survey was designed to explore United Kingdom general practitioner (GP) experiences, opinions, knowledge and needs in relation to depression, ADs and withdrawal. A total of 66 GPs had completed the survey when COVID-19 occurred.

Results: In keeping with previous findings, this small sample of GPs had a predominantly psycho-social perspective on the causes of, and treatments for, depression. They broadly considered ADs effective for moderate/severe depression and ineffective for minimal/mild depression, for which they preferred psychological therapies and social prescribing. There was a marked lack of consistency in GPs' knowledge about the incidence and duration of withdrawal effects. Only a minority (29%) felt their knowledge about withdrawal was 'adequate' and fewer (17%) believed this about their 'Ability to distinguish between withdrawal effects and return of the original problem (e.g. depression)'. Two-thirds (68%) would like more training on these matters.

Conclusion: It is hoped that even this small sample will be helpful when designing, and seeking funding for, GP training programmes, and when implementing the PHE recommendations for support services, based in the primary care system, for the millions of people contemplating or initiating withdrawal from ADs every year in the UK.

Keywords: Antidepressants; Depression; General Practitioners; Primary Care; Training; Withdrawal.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

Similar articles

Cited by

References

    1. Taylor S, Annand F, Burkinshaw P, et al. Dependence and withdrawal associated with some prescribed medicines: An evidence review. London: Public Health England, 2019.
    1. Pratt L, Brody D, Gu Q. Antidepressant use among persons aged 12 and over: United States, 2011–2014. Data Brief No. 283. Washington DC: National Centre for Health Statistics, 2017. - PubMed
    1. Organisation for Economic Cooperation and Development (OECD). Antidepressant drugs consumption, 2000 and 2015 (or nearest year) in Pharmaceutical sector. Paris: OECD, 2017. 10.1787/health_glance-2017-graph181-en (accessed 10 June 2020). - DOI
    1. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018; 391: 1357–1366. - PMC - PubMed
    1. Khan A, Khan S, Brown W. Are placebo controls necessary to test new antidepressants and anxiolytics? Int J Neuropsychopharmacol 2002; 5: 193–197. - PubMed

LinkOut - more resources